腹腔镜胆囊切除术中吲哚菁绿肝外胆道显影的术前给药时间和剂量研究

Study on preoperative administration time and dose of indocyanine green for extrahepatic biliary tract imaging in the laparoscopic cholecystectomy

  • 摘要:
    探讨腹腔镜胆囊切除术(LC)中吲哚菁绿肝外胆道显影的术前给药时间和剂量。
    采用回顾性研究方法。收集2022年12月至2024年12月安徽医科大学第一附属医院收治的252例胆囊疾病患者的临床资料;男137例,女115例;年龄为(45±4)岁。患者均行LC,术前注射1.25 mg或2.50 mg吲哚菁绿,术中应用吲哚菁绿荧光导航。观察指标:(1)术中有效荧光显影情况。(2)胆囊管‑肝脏荧光强度比值及胆总管‑肝脏荧光强度比值情况。(3)肝外胆道显影效果。偏态分布的计量资料多组间比较采用Kruskal⁃Wallis H检验,两两比较采用Bonferroni法。一致性评价采用Kendall检验。
    (1)术中有效荧光显影情况。Kendall协调系数为0.83,医师间肝外胆道显影效果评价一致性程度强。术中有效荧光显影部位位于肝脏、胆囊管、胆总管、胆囊管‑胆总管连接处、肝总管、胆囊。术前静脉注射1.25、2.50 mg吲哚菁绿患者术中有效荧光显影情况显示:随术前注射吲哚菁绿至手术间隔时间的延长,肝脏、胆囊的荧光显影占比均逐渐降低,胆囊管、胆总管、胆囊管‑胆总管连接处、肝总管的荧光显影占比均呈先升高后降低趋势。(2)胆囊管‑肝脏荧光强度比值及胆总管‑肝脏荧光强度比值情况。Kruskal⁃Wallis H检验结果显示:术前静脉注射1.25 mg吲哚菁绿患者至手术不同间隔时间的胆囊管‑肝脏荧光强度比值、胆总管‑肝脏荧光强度比值比较,差异均有统计学意义(H=73.22、77.17,P<0.05);两两比较结果显示:术前4.0~<6.0 h静脉注射吲哚菁绿分别与术前<0.5 h、0.5~<2.0 h、2.0~<4.0 h、6.0~<8.0 h、8.0~<10.0 h、10.0~<12.0 h静脉注射吲哚菁绿患者的胆囊管‑肝脏荧光强度比值、胆总管‑肝脏荧光强度比值比较,差异均有统计学意义(P<0.002)。术前静脉注射2.50 mg吲哚菁绿患者至手术不同间隔时间的胆囊管‑肝脏荧光强度比值、胆总管‑肝脏荧光强度比值比较,差异均有统计学意义(H=127.06、126.39,P<0.05);两两比较结果显示:术前8.0~<10.0 h静脉注射吲哚菁绿分别与术前<0.5 h、0.5~<2.0 h、2.0~<4.0 h、4.0~<6.0 h、6.0~<8.0 h、12.0~<14.0 h、14.0~<16.0 h静脉注射吲哚菁绿患者的胆囊管‑肝脏荧光强度比值、胆总管‑肝脏荧光强度比值比较,差异均有统计学意义(P<0.001)。(3)肝外胆道显影效果。102例术前静脉注射1.25 mg吲哚菁绿患者中,肝外胆道显影效果达到A级的患者例数随间隔时间延长呈先上升后下降趋势,4.0~<6.0 h达到高峰。150例术前静脉注射2.50 mg吲哚菁绿患者中,肝外胆道显影效果达到A级的患者例数随间隔时间延长呈先上升后下降趋势,8.0~<10.0 h达到高峰。
    延长术前注射吲哚菁绿至手术间隔时间,可有效降低肝脏背景的荧光强度、提高胆囊管‑肝脏荧光强度比值和胆总管‑肝脏荧光强度比值,获取最佳的显影效果;术前4.0~<6.0 h静脉注射1.25 mg吲哚菁绿或术前8.0~<10.0 h静脉注射2.50 mg吲哚菁绿,术中肝外胆道显影效果更佳。

     

    Abstract:
    Objective To investigate the preoperative administration time and dose of indo⁃cyanine green (ICG) for extrahepatic biliary tract imaging in the laparoscopic cholecystectomy (LC).
    Methods The retrospective study was conducted. The clinical data of 252 patients with gallbladder diseases who were admitted to The Affiliated Hospital of Anhui Medical University from December 2022 to December 2024 were collected. There were 137 males and 115 females, aged (45±4)years. All patients underwent LC after injection of 1.25 mg or 2.50 mg ICG, with ICG fluore-scence navigation during the operation. Observation indicators: (1) effective fluorescence imaging during surgery; (2) the ratio of fluorescence intensity between gallbladder duct and liver, and the ratio of fluorescence intensity between common bile duct and liver; (3) the imaging effect of extra-hepatic biliary tract. Comparison of measurement data with skewed distribution among groups was conducted using the Kruskal-Wallis H test, and the Bonferroni method was used for pairwise com-parison. The consistency evaluation was conducted using the Kendall test.
    Results (1) Effective fluorescence imaging during surgery. The Kendall coefficient index was 0.83, indicating high consis-tency in evaluation of fluorescence imaging of extrahepatic biliary tract between doctors. The effective fluorescent imaging sites during surgery were located in the liver, cystic duct, common bile duct, cystic duct-common bile duct junction, hepatic duct, and gallbladder. The intraoperative effective fluorescence imaging of patients who received intravenous injection of 1.25 mg and 2.50 mg ICG before surgery showed that as the interval between ICG injection and surgery increased, the proportion of fluorescence imaging in the liver and gallbladder gradually decreased. The proportion of fluorescence imaging in the gallbladder duct, common bile duct, cystic duct-common bile duct junction, common hepatic duct showed a trend of first increasing and then decreasing. (2) The ratio of fluorescence intensity between gallbladder duct and liver, and the ratio of fluorescence intensity between common bile duct and liver. Results of Kruskal Wallis H test showed that there were significant differences in the fluorescence intensity ratios of gallbladder duct to liver and the fluorescence intensity ratio of common bile duct to liver among patients who received intravenous injection of 1.25 mg ICG at different time intervals to surgery (H=73.22, 77.17, P<0.05). Results of pairwise comparison showed that there were significant differences in the fluorescence intensity ratio of gallbladder duct to liver and the fluorescence intensity ratio of common bile duct to liver between patients who received intravenous ICG injection 4.0-<6.0 hours before surgery and those who received ICG injection <0.5 hours, 0.5-<2.0 hours, 2.0-<4.0 hours, 6.0-<8.0 hours, 8.0-<10.0 hours, and 10.0-<12.0 hours before surgery, respectively (P<0.002). There were significant differences in the fluorescence intensity ratio of gallbladder duct to liver and the fluorescence intensity ratio of common bile duct to liver among patients who received intravenous injection of 2.50 mg ICG at different time intervals to surgery (H=127.06, 126.39, P<0.05). Results of pairwise comparison showed there were significant differences in the fluorescence intensity ratio of gall-bladder duct to liver and the fluorescence intensity ratio of common bile duct to liver between patients who received ICG injection 8.0-<10.0 hours before surgery and those who received ICG injection <0.5 hours, 0.5-<2.0 hours, 2.0-<4.0 hours, 4.0-<6.0 hours, 6.0-<8.0 hours, 12.0-<14.0 hours, and 14.0-<16.0 hours before surgery (P<0.001). (3) The imaging effect of extrahepatic biliary tract. Among 102 patients who received preoperative intravenous injection of 1.25 mg ICG, the number of patients with grade A extrahepatic biliary system imaging increased and then decreased as the interval time extending, reaching a peak at 4.0-<6.0 hours. Among 150 patients who received preoperative intravenous injection of 2.50 mg ICG, the number of patients with grade A extrahepatic biliary tract imaging increased and then decreased as the interval time extending, reaching a peak at 8.0-<10.0 hours.
    Conclusion Prolonging the time interval between ICG administration and surgery can effectively reduce the fluorescence intensity of the liver background, thereby increasing the fluorescence intensity ratio of gallbladder duct to liver and common bile duct to liver to obtain the best development effect. Intravenous injection of 1.25 mg ICG 4.0-<6.0 hours before surgery or 2.50 mg ICG 8.0-<10.0 hours before surgery provide better results for intraoperative extrahepatic biliary tract imaging.

     

/

返回文章
返回